These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Fatty acid composition of cholesterol esters in brains of patients with Schilder's disease, G M1 -gangliosidosis and Tay-Sachs disease, and its possible relationship to the -position fatty acids of lecithin. Eto Y; Suzuki K J Neurochem; 1971 Jun; 18(6):1007-16. PubMed ID: 5567894 [No Abstract] [Full Text] [Related]
36. GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease. Hoffman LM; Amsterdam D; Schneck L Brain Res; 1976 Jul; 111(1):109-17. PubMed ID: 953690 [TBL] [Abstract][Full Text] [Related]
37. Conversion of Tay-Sachs ganglioside to monosialoganglioside by brain uridine diphosphate D-galactose: glycolipid galactosyltransferase. Basu S; Kaufman B; Roseman S J Biol Chem; 1965 Oct; 240(10):4115-7. PubMed ID: 5842076 [No Abstract] [Full Text] [Related]
39. Molecular mechanism of Tay-Sachs disease. Lester R; Hill MW; Bangham AD Nature; 1972 Mar; 236(5340):32-3. PubMed ID: 4553636 [No Abstract] [Full Text] [Related]
40. Glycoproteins in brain tissue of the O-variant of GM2 gangliosidosis. Brunngraber EG; Brown BD; Aro A J Neurochem; 1974 Jan; 22(1):125-8. PubMed ID: 4818864 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]